BioSpace News Archive

Business

Calliditas Therapeutics - Year-end report, 2018

2018 was an exciting and transformational year for Calliditas.

February 7, 2019
·
3 min read
Business

Hansa Biopharma Appoints Donato Spota as New Chief Financial Officer

Hansa Biopharma AB, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced the appointment of Mr. Donato Spota as new Chief Financial Officer, effective May 15, 2019.

February 7, 2019
·
3 min read
Business

FSD Pharma Signs Collaboration and Profit-Sharing Agreement with Pharmastrip for Production and Delivery of Organic Medical Cannabis Infused in Oral Thin Film Strips

FSD receives exclusive, perpetual license to manufacture and sell oral film strips in Canada

February 7, 2019
·
4 min read
Business

Tilray® Expands Leadership Team in Europe to Drive Global Expansion Strategy

Former pharmaceutical leader from Grünenthal joins Tilray, strengthening the company’s position in Europe

February 7, 2019
·
4 min read
Sobi Presents Comprehensive Study Data on Extended Half-life Haemophilia Treatments at EAHAD

Sobi™ will present data at the European Association of Haemophilia and Allied Disorders conference in Prague, Czech Republic, 6-8 February 2019, showing evidence on the safety, efficacy and long-term benefits of its extended half-life products for the treatment of haemophilia.

February 7, 2019
·
8 min read
Business

Arcadia Biosciences’ GoodWheat™ Supply Chain Is Progressing in Two Hemispheres

Winter planting expands acres and builds supply for commercial launch

February 7, 2019
·
4 min read
Business

Biotage: Year-end Report January - December 2018

Continued strong growth and increased operating profit

February 7, 2019
·
8 min read
Business

Encision Reports Third Quarter Fiscal Year 2019 Results

Encision Inc. announced financial results for its fiscal 2019 third quarter that ended December 31, 2018.

February 7, 2019
·
6 min read
BioCapital

Apex Systems Wins ClearlyRated’s 2019 Best of Staffing® Client and Talent Awards

Earned by less than two percent of all staffing agencies in the U.S. and Canada

February 7, 2019
·
4 min read
Deals

DelMar Pharmaceuticals Receives Nasdaq Listing Extension

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new cancer therapies, announced that it has received a listing extension from the Nasdaq Hearings Panel.

February 7, 2019
·
4 min read